Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vintafolide (EC145) for the treatment of folate-receptor-a positive platinum-resistant ovarian cancer.

Vintafolide (EC145) for the treatment of folate-receptor-a positive platinum-resistant ovarian cancer. Expert Rev Clin Pharmacol. 2014 Jul; 7(4):443-50.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.